ß-endorphin modulates the effect of stress on novelty-suppressed feeding

Frontiers in Behavioral Neuroscience

Volumn , Issue FEB, 2013, Pages

  Barfield, Elizabeth T ^a   Alexandra Moser, V ^a,b   Hand, Annie ^a   Grisel, Judith E ^a,c  

^a FURMAN UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c BUCKNELL UNIVERSITY   (United States)

Author keywords

Anxiety; Depression; Hyponeophagia; Mice; Novelty; Opioids; Transgenic

Indexed keywords

BETA ENDORPHIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; COPING BEHAVIOR; ENVIRONMENTAL STRESS; FEMALE; FOOD AVERSION; FOOD DEPRIVATION; FORCED SWIMMING TEST; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; LIFE STRESS; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PROTEIN FUNCTION;

EID: 84874717369     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2013.00019     Document Type: Article

References (85)

1. Amir, S. (1982). Involvement of endogenous opioids with forced swimming-induced immobility in mice. Physiol. Behav. 28, 249-251.
2. Bardeleben, U., and Holsboer, F. (1989). Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J. Neuroendocrinol. 1, 485-488.
3. Barfield, E. T., Barry, S. M., Hodgin, H. B., Thompson, B. M., Allen, S. A., and Grisel, J. E. (2010). β-endorphin mediates behavioral despair and the effect of ethanol on the tail suspension test in mice. Alcohol. Clin. Exp. Res. 34, 1066-1072.
4. Bessa, J. M., Mesquita, A. R., Oliveira, M., Pêgo, J. M., Cerqueira, J. J., Palha, J. A., Almeida, O. F., and Sousa, N. (2009). A trans-dimensional approach to the behavioral aspects of depression. Front. Behav. Neurosci. 3, 1-7.
5. Bet, P. M., Penninx, B. W., Bochdanovits, Z., Uitterlinden, A. G., Beekman, A. T., van Schoor, N. M., Deeg, D. J., and Hoogendijk, W. J. (2009). Glucocorticoid receptor gene polymorphisms and childhood adversity are associated with depression: new evidence for a gene-environment interaction. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 150B, 660-669.
6. Bodnar, R. J., Kelly, D. D., Brutus, M., and Glusman, M. (1980). Stress-induced analgesia: neural and hormonal determinants. Neurosci. Biobehav. Rev. 4, 87-100.
7. Bodnoff, S. R., Suranyi-Cadotte, B., Aitken, D. H., Quirion, R., and Meaney, M. J. (1988). The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berl) 95, 298-302.
8. Branchi, I., and Ricceri, L. (2002). Transgenic and knock-out mouse pups: the growing need for behavioral analysis. Genes Brain Behav. 1, 135-141.
9. Britton, D. R., and Britton, K. T. (1981). A sensitive open field measure of anxiolytic drug activity. Pharmacol. Biochem. Behav. 15, 577-582.
10. Brown, G. W., Bifulco, A., and Harris, T. O. (1987). Life events, vulnerability and onset of depression: some refinements. Br. J. Psychiatry. 150, 30-42.
11. Carroll, B. J., Cassidy, F., Naftolowitz, D., Tatham, N. E., Wilson, W. H., Iranmanesh, A., Liu, P. Y., and Veldhuis, J. D. (2007). Pathophysiology of hypercortisolism in depression. Acta. Pschiatr. Scand. Suppl. 433, 90-103.
12. Carver, C. S., and Connor-Smith, J. (2010). Personality and coping. Annu. Rev. Psychol. 61, 679-704.
13. Castro, J. E., Diessler, S., Varea, E., Márquez, C., Larsen, M. H., Cordero, M. I., and Sandi, C. (2012). Personality traits in rats predict vulnerability and resilience to developing stress induced depression-like behaviors, HPA axis hyper-reactivity and brain changes in pERK1/2 activity. Psychoneuroendocrinol. 37, 1209-1223.
14. Charmandari, E., Tsigos, C., and Chrousos, G. (2005). Endocrinology of the stress response. Annu. Rev. Physiol. 67, 259-284.
15. Chong, R. Y., Oswald, L., Yang, X., Uhart, M., Lin, P. I., and Wand, G. S. (2006). The mu opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology 31, 204-211.
16. Constantopoulos, A., Papadaki-Papandreou, U., and Papaconstantinou, E. (1995). Increased beta endorphin but not leu-enkephalin in plasma due to preoperative stress. Experientia 51, 16-18.
17. Cryan, J. F., and Sweeney, F. F. (2011). The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br. J. Pharmacol. 164, 1129-1161.
18. Dai, X., Thavundayil, J., and Gianoulakis, C. (2002). Differences in the responses of the pituitary beta-endorphin and cardiovascular system to ethanol and stress as a function of family history. Alcohol. Clin. Exp. Res. 26, 1171-1180.
19. Dai, X., Thavundayil, J., and Gianoulakis, C. (2005). Differences in the peripheral levels of beta endorphin in response to alcohol and stress as a function of alcohol dependence and family history of alcoholism. Alcohol. Clin. Exp. Res. 29, 1965-1975.
20. Danese, A. (2008). Genetic opportunities for psychiatric epidemiology: on life stress and depression. Epidemiol. Psichiatr. Soc. 17, 201-210.
21. de Rijk, R., and de Kloet, E. R. (2005). Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine 28, 263-270.
22. Feder, A., Nestler, E. J., and Charney, D. S. (2009). Psychobiology and molecular genetics of resilience. Nat. Rev. Neurosci. 10, 446-457.
23. Federenko, I. S., Nagamine, M., Hellhammer, D. H., Wadhwa, P. D., and Wüst, S. (2004). The heritability of hypothalamus pituitary adrenal axis responses to psychosocial stress is context dependent. J. Clin. Endocrinol. Metab. 89, 6244-6250.
24. Gianoulakis, C. (1998). Alcohol-seeking behavior: the roles of the hypothalamic-pituitary adrenal axis and the endogenous opioid system. Alcohol. Health Res. World 22, 202-210.
25. Gorman, J. M. (1996). Comorbid depression and anxiety spectrum disorders. Depress. Anxiety 4, 160-168.
26. Gorwood, P. (2004). Generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy? Eur. Psychiatry 19, 27-33.
27. Grisel, J. E., Bartels, J. L., Allen, S. A., and Turgeon, V. L. (2008). Influence of β-endorphin on anxious behavior in mice: interaction with EtOH. Psychopharmacology 200, 105-115.
28. Hammen, C., Davila, J., Brown, G., Ellicott, A., and Gitlin, M. (1992). Psychiatric history and stress: predictors of severity of unipolar depression. J. Abnorm. Psychol. 101, 45-52.
29. Hasin, D. S., Stinson, F. S., Ogburn, E., and Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 64, 830-42.
30. Hegadoren, K. M., O'Donnell, T., Lanius, R., Coupland, N. J., and Lacaze-Masmonteil, N. (2009). The role of beta-endorphin in the pathophysiology of major depression. Neuropeptides 43, 341-353.
31. Hettema, J. M., Neale, M. C., and Kendler, K. S. (2001). A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry 158, 1568-1578.
32. Hettema, J. M., Prescott, C. A., and Kendler, K. S. (2003). The effects of anxiety, substance abuse and conduct disorders on risk of major depressive disorder. Psychol. Med. 33, 1423-1432.
33. Heuser, I., Yassouridis, A., and Holsboer, F. (1994). The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 28, 341-356.
34. Holsboer, F., Lauer, C. J., Schreiber, W., and Krieg, J-C. (1995) Altered hypothalamic-pituitary adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62, 340-347.
35. Hossain, S. M., Wong, B. K., and Simpson, E. M. (2004). The dark phase improves genetic discrimination for some high throughput mouse behavioral testing. Genes Brain Behav. 3, 167-177.
36. Kaufman, J., and Charney, D. (2000). Comorbidity of mood and anxiety disorders. Depress. Anxiety 12 (Suppl 1), 69-76.
37. Kendler, K. S., Gardner, C. O., Gatz, M., and Pedersen, N. L. (2007). The sources of co morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol. Med. 37, 453-462.
38. Kendler, K. S., Gatz, M., Gardner, C. O., and Pedersen, N. L. (2006a). Personality and maj or depression: a Swedish longitudinal, population-based twin study. Arch. Gen. Psychiatry 63, 1113-1120.
39. Kendler, K. S., Gatz, M., Gardner, C. O., and Pedersen, N. L. (2006b). A Swedish national twin study of lifetime major depression. Am. J. Psychiatry 163, 109-114.
40. Kendler, K. S., Kessler, R. C., Heath, A. C., Neale, M. C., and Eaves, L. J. (1991). Coping: a genetic epidemiological investigation. Psychol. Med. 21, 337-346.
41. Kendler, K. S., Neale, M. C., Kessler, R. C., Heath, A. C., and Eaves, L. J. (1992a). Childhood parental loss and adult psychopathology in women. Arch. Gen. Psychiatry 49, 109-116.
42. Kendler, K. S., Neale, M. C., Kessler, R. C., Heath, A. C., and Eaves, L. J. (1992b). Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch. Gen. Psychiatry 49, 716-722.
43. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., and Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch. Gen. Psychiatry 62, 593-602.
44. Kessler, R. C., Gruber, M., Hettema, J. M., Hwang, I., Sampson, N., and Yonkers, K. A. (2008). Co-morbid major depression and generalized anxiety disorders in the national comorbidity survey follow-up. Psychol. Med. 38, 365-374.
45. Kessler, R. C., McGonagle, K. A., Swartz, M., Blazer, D. G., and Nelson, C. B. (1993). Sex and depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity and recurrence. J. Affect. Disord. 29 (2-3), 85-96.
46. Kessler, R. C., Nelson, C. B., McGonagle, K. A., Liu, J., Swartz, M., and Blazer, D. G. (1996). Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US national comorbidity survey. Br. J. Psychiatry Suppl. (30), 17-30.
47. Krueger, R. F. (1999). The structure of common mental disorders. Arch. Gen. Psychiatry 56, 921-926.
48. Kunugi, H., Hori, H., Adachi, N., and Numakawa, T. (2010). Interface between hypothalamic pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry Clin. Neurosci. 64, 447-459.
49. Lee-Bagley, D., Preece, M., and DeLongis, A. (2005). Coping with interpersonal stress: role of Big Five traits. J. Personal. 73, 1141-1180.
50. LeSauter, J., Hoque, N., Weintraub, M., Pfaff, D. W., and Silver, R. (2009). Stomach ghrelin secreting cells as food-entrainable circadian clocks. Proc. Natl. Acad. Sci. USA. 106, 13582-13587.
51. Levinson, D. F. (2006). The genetics of depression: a review. Biol. Psychiatry 60, 84-92.
52. Lloyd, R. B., and Nemeroff, C. B. (2011). The role of corticotropin-releasing hormone in the pathophysiology of depression: therapeutic implications. Curr. Top. Med. Chem. 11, 609-617.
53. Low, M. J. (2004). Role of proopiomelanocortin neurons and peptides in the regulation of energy homeostasis. J. Endocrinol. Invest. 27(6 Suppl), 95-100.
54. Mahmoud, J. S., Staten, R., Hall, L. A., and Lennie, T. A. (2012). The relationship among young adult college students' depression, anxiety, stress, demographics, life satisfaction, and coping styles. Issues Ment. Health Nurs. 33, 149-156.
55. Marcus, S. M., Young, E. A., Kerber, K. B., Kornstein, S., Farabaugh, A. H., Mitchell, J., Wisniewski, S. R., Balasubramani, G. K., Trivedi, M. H., and Rush, A. J. (2005) Gender differences in depression: findings from the STAR*D study. J. Affect. Disord. 87 (2-3), 141-150.
56. McEwen, B. S. (2002). Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol. Aging 23, 921-939.
57. McEwen, B. S. (2003). Early life influences on life-long patterns of behavior and health. Ment. Retard. Dev. Disabil. Res. Rev. 9, 149-154.
58. Meng, X. H., Tao, F. B., Wan, Y. H., Hu, Y., and Wang, R. X. (2011). Coping as a mechanism linking stressful life events and mental health problems in adolescents. Biomed. Environ. Sci. 24, 649-655.
59. Merali, Z., Levac, C., and Anisman, H. (2003). Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol. Psychiatry 54, 552-565.
60. Merenlender-Wagner, A., Dikshtein, Y., and Yadid, G. (2009). The beta-endorphin role in stress related psychiatric disorders. Curr. Drug Targets 10, 1096-1108.
61. Nakagawasai, O., Tadano, T., Tan No, K., Niijima, F., Sakurada, S., Endo, Y., and Kisara, K. (1999). Changes in beta-endorphin and stress-induced analgesia in mice after exposure to forced walking stress. Methods Find. Exp. Clin. Pharmacol. 21, 471-476.
62. Ohara, K., Suzuki, Y., Ochiai, M., Tsukamoto, T., Tani, K., and Ohara, K. (1999). A variable number-tandem-repeat of the serotonin transporter gene and anxiety disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 23, 55-65.
63. Parikh, D., Hamid, A., Friedman, T. C., Nguyen, K., Tseng, A., Marquez, P., and Lutfy, K. (2011). Stress-induced analgesia and endogenous opioid peptides: the importance of stress duration. Eur. J. Pharmacol. 650, 563-567.
64. Porsolt, R. D., le Pichon, M., and Jalfre, M. (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730-732.
65. Ribeiro, S. C., Kennedy, S. E., Smith, Y. R., Stohler, C. S., and Zubieta, J. K. (2005). Interface of physical and emotional stress regulation through the endogenous opioid system and mu opioid receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1264-1280.
66. Roedel, A., Storch, C., Holsboer, F., and Ohl, F. (2006). Effects of light or dark phase testing on behavioral and cognitive performance in DBA mice. Lab. Anim. 40, 371-381.
67. Rubin, R. T., Phillips, J. J., Sadow, T. F., McCracken, J. T. (1995). Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch. Gen. Psychiatry 52, 213-218.
68. Rubinstein, M., Mogil, J. S., Japón, M., Chan, E. C., Allen, R. G., and Low, M. J. (1996). Absence of opioid stress-induced analgesia in mice lacking β-endorphin by site-directed mutagenesis. Proc. Natl. Acad. Sci. USA 93, 3995-4000.
69. Sandi, C., Cordero, M. I., Ugolini, A., Varea, E., Caberlotto, L., and Large, C. H. (2008). Chronic stress-induced alterations in amygdala responsiveness and behavior-modulation by trait anxiety and corticotropin-releasing factor systems. Eur. J. Neurosci. 28, 1836-1848.
70. Sandi, C., and Richter-Levin, G. (2009). From high anxiety trait to depression: a neurocognitive hypothesis. Trends Neurosci. 32, 312-320.
71. Sarkar, D. K., Kuhn, P., Marano, J., Chen, C., and Boyadjieva, N. (2007). Alcohol exposure during the developmental period induces beta-endorphin neuronal death and causes alteration in the opioid control of stress axis function. Endocrinology 148, 2828-2834.
72. Schedlowski, M., Flüge, T., Richter, S., Tewes, U., Schmidt, R. E., and Wagner, T. O. (1995). Beta-endorphin, but not substance-P, is increased by acute stress in humans. Psychoneuroendocrinology 20, 103-110.
73. Schwandt, M. L., Lindell, S. G., Higley, J. D., Suomi, S. J., Heilig, M., Barr, C. S. (2011). OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors in rhesus macaques. Psychoneuroendocrinology 36, 1303-1311.
74. Shephard, R. A., Hewitt, J. K., Broadhurst, P. L. (1985). The genetic architecture of hyponeophagia and the action of diazepam in rats. Behav. Genet. 15, 265-286.
75. Southwick, S. M., Vythilingam, M., Charney, D. S. (2005). The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu. Rev. Clin. Psychol. 1, 255-291.
76. Stiller, A. L., Drugan, R. C., Hazi, A., and Kent, S. P. (2011). Stress resilience and vulnerabilit y: the association with rearing conditions, endocrine function, immunology, and anxious behavior. Psychoneuroendocrinology 36, 1383-1395.
77. Sullivan, P. F., Neale, M. C., and Kendler, K. S. (2000). Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157, 1552-1562.
78. Unschuld, P. G., Ising, M., Specht, M., Erhardt, A., Ripke, S., Heck. A., Kloiber, S., Straub, V., Brueckl, T., Müller-Myhsok, B., Holsboer. F., and Binder, E. B. (2009). Polymorphisms in the GAD2 gene-region are associated with susceptibility for unipolar depression and with a risk factor for anxiety disorders. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 150B, 1100-1109.
79. van Santen, A., Vreeburg, S. A., Van der Does, A. J., Spinhoven, P., Zitman, F. G., and Penninx, B. W. (2011). Psychological traits and the cortisol awakening response: results from the Netherlands study of depression and anxiety. Psychoneuroendocrinology 36, 240-248.
80. Vollebergh, W. A., Iedema, J., Bijl, R. V., de Graaf, R., and Ormel, J. (2001). The structure and stability of common mental disorders: the NEMESIS study. Arch. Gen. Psychiatry 58, 597-603.
81. Wüst, S., Federenko, I., Hellhammer, D. H., and Kirschbaum, C. (2000). Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 25, 707-720.
82. Yamada, K., and Nabeshima, T. (1995). Stress-induced behavioral responses and multiple opioid systems in the brain. Behav. Brain Res. 67, 133-145.
83. Young, E. A., Haskett, R. F., Murphy-Weinberg, V., Watson, S. J., and Akil, H. (1991). Loss of glucocorticoid fast feedback in depression. Arch. Gen. Psychiatry 48, 693-699.
84. Yu, H,. Wang, D. D., Wang, Y., Liu, T., Lee, F. S., and Chen, Z. Y. (2012). Variant brain derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J. Neurosci. 32, 4092-4101.
85. Zilberman, M. L., Tavares, H., Blume, S. B., and el-Guebaly, N. (2003). Substance use disorders: sex differences and psychiatric comorbidities. Can. J. Psychiatry 48, 5-13.